Literature DB >> 4986007

Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects.

L E Braverman, S H Ingbar, K Sterling.   

Abstract

Studies of the possibility that thyroxine (T4) is converted to 3.5,3'-triiodo-L-thyronine (T3) in the extrathyroidal tissues in man have been conducted in 13 patients, all but two of whom were athyreotic or hypothyroid, and all of whom were receiving at least physiological replacement doses of synthetic sodium-L-thyroxine.T3 was found in the sera of all patients, in concentrations ranging between 243 and 680 ng/100 ml (normal range 170-270 ng/100 ml). These concentrations were far in excess of those which would have been expected on the basis of the T3 contamination of the administered T4, as measured by the same technique employed in the analysis of serum. When oral medication was enriched with (125)I-labeled T4 for 8 or more days, labeled T3 and tetraiodothyroacetic acid (Tetrac or TA(4)) were found in the serum to the extent of approximately 2-5% of total radioactivity, as assessed by unidimensional paper chromatography. The same results were obtained with a specially purified lot of radioactive T4 containing less than 0.1% T3 as a contaminant. The identities of the (125)I-labeled T3 and TA(4) were verified by two-dimensional chromatography as well as by specific patterns of binding in serum. The labeled T3 isolated was bound by albumin and by T4-binding globulin (TBG), but not by T4-binding prealbumin (TBPA): in contrast the labeled TA(4) was bound by albumin and TBPA, but not by TBG. To exclude the possibility that the conversion of T4 to T3 was a peculiarity of the oral route of administration, the sera of two additional patients were obtained 48 hr after 7-day courses of daily intravenous injections of a mixture of stable and (125)I-labeled T4. Both stable and labeled T3 were likewise found in these sera. In contrast to earlier experiments in humans in which (131)I-labeled T3 was not definitively demonstrated in serum after a single intravenous injection of (131)I-labeled T4, the present findings are taken to provide conclusive evidence of the extrathyroidal conversion of T4 to T3 in man. These results raise once again the question of the extent to which the metabolic effect of T4 is mediated through the peripheral generation of T3.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4986007      PMCID: PMC535757          DOI: 10.1172/JCI106304

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  DETERMINATION OF THYROXINE UTILIZING THE PROPERTY OF PROTEIN-BINDING.

Authors:  B E MURPHY; C J PATTEE
Journal:  J Clin Endocrinol Metab       Date:  1964-02       Impact factor: 5.958

2.  Conversion of thyroxine to 3-5-3'-triiodothyronine in vivo.

Authors:  R PITT-RIVERS; J B STANBURY; B RAPP
Journal:  J Clin Endocrinol Metab       Date:  1955-05       Impact factor: 5.958

3.  Some notes on the exchange of iodine with thyroxine homologues.

Authors:  G I GLEASON
Journal:  J Biol Chem       Date:  1955-04       Impact factor: 5.157

4.  Disappearance of I-131-triiodo-thyronine from the plasma in the presence of fever.

Authors:  J G WISWELL; V CORONHO
Journal:  J Clin Endocrinol Metab       Date:  1962-06       Impact factor: 5.958

5.  Observations concerning the binding of thyroid hormones by human serum prealbumin.

Authors:  S H INGBAR
Journal:  J Clin Invest       Date:  1963-02       Impact factor: 14.808

6.  Enzymatic conversion of thyroxine and triiodothyronine to the corresponding acetic acid analogues.

Authors:  E C ALBRIGHT; H A LARDY; F C LARSON; K TOMITA
Journal:  Endocrinology       Date:  1956-08       Impact factor: 4.736

7.  Effect of 3:5:3'-L-triiodothyronine in myxoedema.

Authors:  J GROSS; R PITT-RIVERS; W R TROTTER
Journal:  Lancet       Date:  1952-05-24       Impact factor: 79.321

8.  The identification of 3:5:3'-L-triiodothyronine in human plasma.

Authors:  J GROSS; R PITT-RIVERS
Journal:  Lancet       Date:  1952-03-01       Impact factor: 79.321

9.  Metabolites of thyroxine.

Authors:  J GROSS; C P LEBLOND
Journal:  Proc Soc Exp Biol Med       Date:  1951-04

10.  Thyroxine transport in thyrotoxicosis and hypothyroidism.

Authors:  M Inada; K Sterling
Journal:  J Clin Invest       Date:  1967-09       Impact factor: 14.808

View more
  112 in total

Review 1.  Semistarvation: an overview of an old problem.

Authors:  J L Barbosa-Saldivar; T B Van Itallie
Journal:  Bull N Y Acad Med       Date:  1979-09

2.  The radioimmunoassay of triiodothyronine and its clinical application.

Authors:  C J Eastman; J M Corcoran; R P Ekins; E S Williams; J D Nabarro
Journal:  J Clin Pathol       Date:  1975-03       Impact factor: 3.411

3.  Conversion of thyroxine into tri-iodothyronine by rat liver homogenate.

Authors: 
Journal:  Biochem J       Date:  1975-09       Impact factor: 3.857

4.  Highlights in thyroidology: a historical vignette.

Authors:  Michael Weissel
Journal:  Wien Klin Wochenschr       Date:  2014-03-21       Impact factor: 1.704

5.  Estimation of thyroxine and triiodothyronine distribution and of the conversion rate of thyroxine to triiodothyronine in man.

Authors:  M Inada; K Kasagi; S Kurata; Y Kazama; H Takayama; K Torizuka; M Fukase; T Soma
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

Review 6.  Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling.

Authors:  Balázs Gereben; Ann Marie Zavacki; Scott Ribich; Brian W Kim; Stephen A Huang; Warner S Simonides; Anikó Zeöld; Antonio C Bianco
Journal:  Endocr Rev       Date:  2008-09-24       Impact factor: 19.871

Review 7.  Thyroid hormone action in metabolic regulation.

Authors:  Yiyun Song; Xuan Yao; Hao Ying
Journal:  Protein Cell       Date:  2011-05-26       Impact factor: 14.870

Review 8.  Thyroid hormone therapy for hypothyroidism.

Authors:  Bernadette Biondi; David S Cooper
Journal:  Endocrine       Date:  2019-08-01       Impact factor: 3.633

9.  Reduction in extrathyroidal triiodothyronine production by propylthiouracil in man.

Authors:  M Saberi; F H Sterling; R D Utiger
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

10.  Propylthiouracil blocks extrathyroidal conversion of thyroxine to triiodothyronine and augments thyrotropin secretion in man.

Authors:  D L Geffner; M Azukizawa; J M Hershman
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.